Effectiveness of Glucocorticoids in Orthognathic Surgery: an overview of systematic reviews

Author(s):  
Maximiliano Bravo Valenzuela ◽  
Josefina Bendersky Kohan ◽  
Macarena Uribe Monasterio
2019 ◽  
Vol 48 (11) ◽  
pp. 1415-1433 ◽  
Author(s):  
O.L. Haas Junior ◽  
R. Guijarro-Martínez ◽  
A.P. de Sousa Gil ◽  
L. da Silva Meirelles ◽  
N. Scolari ◽  
...  

Author(s):  
O.L. Haas Junior ◽  
R. Guijarro-Martínez ◽  
A.P.S. Gil ◽  
L.S. Meirelles ◽  
N. Scolari ◽  
...  

Author(s):  
Ariane Paredes de Sousa Gil ◽  
Orion Luiz Haas Jr ◽  
Agustin Machado-Fernández ◽  
Mauricio Esteban Muñoz-Pereira ◽  
Bibiana Daldasso Velasques ◽  
...  

2020 ◽  
Vol 26 (23) ◽  
pp. 2686-2691 ◽  
Author(s):  
Ioannis Doundoulakis ◽  
Christina Antza ◽  
Haralambos Karvounis ◽  
George Giannakoulas

Background: Anticoagulation in patients with pulmonary embolism. Objective: To identify how non-vitamin K antagonist oral anticoagulants are associated with multiple outcomes in patients with pulmonary embolism. Methods: We performed a systematic search of systematic reviews via multiple electronic databases from inception to August 19th, 2019, without language restriction. Two authors independently extracted data and assessed the methodological quality of the included systematic reviews using the ROBIS tool. Results: We found twelve systematic reviews. Eleven SRs collected their data from randomized clinical trials and one from observational studies. All the included studies were published between 2014 and 2019 in English. The methodological quality of the 12 systematic reviews was low to high. None of the systematic reviews, which are included in our overview of systematic reviews, has evaluated the overall quality of evidence outcome using the Grading of Recommendations Assessments, Development and Evaluation (GRADE) approach. Conclusion: This is the first effort to summarize evidence about non-vitamin K antagonist oral anticoagulants in an overview of systematic reviews focusing exclusively on patients with pulmonary embolism. The evidence suggests that the non-vitamin K antagonist oral anticoagulants seem to be more effective and safer than a dualdrug approach with LMWH- VKA.


2015 ◽  
Vol 10 (3) ◽  
pp. 204-212 ◽  
Author(s):  
Jenni Ilomaki ◽  
Natali Jokanovic ◽  
Edwin Tan ◽  
Eija Lonnroos

Author(s):  
Fatemeh Khademian ◽  
Azam Aslani ◽  
Peivand Bastani

Abstract Objectives Despite a large number of mobile apps in the field of mental health, it is difficult to find a useful and reliable one, mainly due to the fact that the effectiveness of many apps has not been assessed scientifically. The present study aimed to assess the effects of mental health apps on managing the symptoms of stress, anxiety, and depression. Methods A comprehensive literature search was conducted in PubMed, Scopus, EMBASE, Cochrane, and Web of Science databases for the papers published from 2000 to 2019. Studies were included if they reviewed articles or mobile apps for their effectiveness in stress, anxiety, and depression. The reviews that had considered mobile apps or web-based mobile applications as an intervention or part of intervention were included, as well. Results A total of 4,999 peer-reviewed articles were identified, out of which nine systematic reviews met the inclusion criteria. Seven systematic reviews measured depression outcomes, three measured stress, and five systematic reviews measured anxiety symptoms. The applications that used behavior change strategies, such as Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Behavioral Activation, reported significant effects on depression, anxiety, and stress. Conclusion It seems that mental health apps can be promising media for reducing depressive symptoms. This field is an emerging area of mobile health, and further research should be done in future in order to reach conclusive evidence.


Sign in / Sign up

Export Citation Format

Share Document